Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chi Mei Group is a prominent Taiwanese conglomerate with a significant presence in the healthcare and life sciences sectors, primarily through its subsidiary, the Chi Mei Medical Center. As one of the largest medical systems in Taiwan, it integrates comprehensive clinical services with advanced medical research and education. The group also operates Chi Mei Pharmaceutical, which focuses on the distribution of pharmaceuticals and medical devices, and Chi Mei Biotech, which applies biotechnological innovations to agriculture and health supplements. While the group's origins are in the chemical and plastics industries, its healthcare division has become a cornerstone of its operations, focusing on precision medicine, oncology, and clinical trial management. The organization is recognized for its commitment to medical excellence and its role as a major hub for clinical research in the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chi Mei Group.